AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/111
CORONARY EVENT AND CASE-FATALITY RATES IN AN ENGLISH POPULATION - RESULTS OF THE OXFORD MYOCARDIAL-INFARCTION INCIDENCE STUDY
Authors: VOLMINK JA NEWTON JN HICKS NR SLEIGHT P FOWLER GH NEIL HAW
Citation: Ja. Volmink et al., CORONARY EVENT AND CASE-FATALITY RATES IN AN ENGLISH POPULATION - RESULTS OF THE OXFORD MYOCARDIAL-INFARCTION INCIDENCE STUDY, HEART, 80(1), 1998, pp. 40-44
LIPOPHILIC VERSUS HYDROPHILIC BETA(1) BLOCKERS AND THE CARDIAC SYMPATHOVAGAL BALANCE DURING STRESS AND DAILY ACTIVITY IN PATIENTS AFTER ACUTE MYOCARDIAL-INFARCTION
Authors: KARDOS A LONG V BRYANT J SINGH J SLEIGHT P CASADEI B
Citation: A. Kardos et al., LIPOPHILIC VERSUS HYDROPHILIC BETA(1) BLOCKERS AND THE CARDIAC SYMPATHOVAGAL BALANCE DURING STRESS AND DAILY ACTIVITY IN PATIENTS AFTER ACUTE MYOCARDIAL-INFARCTION, HEART, 79(2), 1998, pp. 153-160
ENTHUSIASM, REALITY, AND COST-EFFECTIVENESS ANALYSIS
Authors: BROPHY JM SLEIGHT P
Citation: Jm. Brophy et P. Sleight, ENTHUSIASM, REALITY, AND COST-EFFECTIVENESS ANALYSIS, HEART, 79(1), 1998, pp. 9-10
ISIS-2 - 10-YEAR SURVIVAL AMONG PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION IN RANDOMIZED COMPARISON OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER
Authors: BAIGENT C COLLINS R APPLEBY P PARISH S SLEIGHT P PETO R
Citation: C. Baigent et al., ISIS-2 - 10-YEAR SURVIVAL AMONG PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION IN RANDOMIZED COMPARISON OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER, BMJ. British medical journal, 316(7141), 1998, pp. 1337-1343
CHEYNE-STOKES RESPIRATION DURING AWAKE DAYTIME IN CHRONIC HEART-FAILURE - PROGNOSTIC IMPLICATION
Authors: MORTARA A PINNA GD MAESTRI R LAROVERE MT TRAVERSI E OPASICH C SLEIGHT P TAVAZZI L
Citation: A. Mortara et al., CHEYNE-STOKES RESPIRATION DURING AWAKE DAYTIME IN CHRONIC HEART-FAILURE - PROGNOSTIC IMPLICATION, Journal of the American College of Cardiology, 31(2), 1998, pp. 249-250
RATIONALE AND DESIGN FOR THE CONTROLLED ONSET VERAPAMIL INVESTIGATIONOF CARDIOVASCULAR END-POINTS (CONVINCE) TRIAL
Authors: BLACK HR ELLIOTT WJ NEATON JD GRANDITS G GRAMBSCH P GRIMM RH HANSSON L LACOUCIERE Y MULLER J SLEIGHT P WEBER MA WHITE WB WILLIAMS G WITTES J ZANCHETTI A FAKOUHI TD
Citation: Hr. Black et al., RATIONALE AND DESIGN FOR THE CONTROLLED ONSET VERAPAMIL INVESTIGATIONOF CARDIOVASCULAR END-POINTS (CONVINCE) TRIAL, Controlled clinical trials, 19(4), 1998, pp. 370-390
THE SYMPATHETIC NERVOUS-SYSTEM IN HYPERTENSION - DIFFERING EFFECTS OFDRUG-TREATMENT
Authors: SLEIGHT P
Citation: P. Sleight, THE SYMPATHETIC NERVOUS-SYSTEM IN HYPERTENSION - DIFFERING EFFECTS OFDRUG-TREATMENT, European heart journal, 19, 1998, pp. 39-44
EXPERIENCE FROM CONTROLLED TRIALS OF PHYSICAL-TRAINING IN CHRONIC HEART-FAILURE - PROTOCOL AND PATIENT FACTORS IN EFFECTIVENESS IN THE IMPROVEMENT IN EXERCISE TOLERANCE
Authors: MAUGERI FS CAMPANA M FERRARI R GIORDANO A SCALVINI S VOLTERRANI M BERNARDI L CALCIATI A FINARDI G PERLINI S RADAELLI A SOLDA PL ADAMOPOULOS S COATS AJS CHUA TP PIEPOLI M POOLEWILSON PA PONIKOWSKI P VOLTERRANI M WEBBPEPLOE K BARLOW C CONWAY J DAVEY PP MEYER TE PATERSON DJ ROBBINS P SLEIGHT P KARA T SOUCE M SPINAROVA L STEJFA M TOMAN J ZATLOUKAL B SZELEMERY R WRABEC K
Citation: Fs. Maugeri et al., EXPERIENCE FROM CONTROLLED TRIALS OF PHYSICAL-TRAINING IN CHRONIC HEART-FAILURE - PROTOCOL AND PATIENT FACTORS IN EFFECTIVENESS IN THE IMPROVEMENT IN EXERCISE TOLERANCE, European heart journal, 19(3), 1998, pp. 466-475
CONWAY,JAMES - 1921-1998 - IN-MEMORIAM
Authors: SLEIGHT P FROHLICH ED
Citation: P. Sleight et Ed. Frohlich, CONWAY,JAMES - 1921-1998 - IN-MEMORIAM, Hypertension, 32(4), 1998, pp. 635-635
INDICATIONS FOR ACE-INHIBITORS IN THE EARLY TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - SYSTEMATIC OVERVIEW OF INDIVIDUAL DATA FROM 100,000 PATIENTS IN RANDOMIZED TRIALS
Authors: FRANZOSI MG SANTORO E ZUANETTI G BAIGENT C COLLINS R FLATHER M KJEKSHUS J LATINI R LIU LS MAGGIONI AP SLEIGHT P SWEDBERG K TOGNONI G YUSUF S TAVAZZI L BALL S KOBER L TORPPEDERSEN C BRAUNWALD E MOYE L PFEFFER M SANTORO L POGUE J WANG Y
Citation: Mg. Franzosi et al., INDICATIONS FOR ACE-INHIBITORS IN THE EARLY TREATMENT OF ACUTE MYOCARDIAL-INFARCTION - SYSTEMATIC OVERVIEW OF INDIVIDUAL DATA FROM 100,000 PATIENTS IN RANDOMIZED TRIALS, Circulation, 97(22), 1998, pp. 2202-2212
EFFECT OF ATENOLOL OR METOPROLOL ON WAKING HOUR DYNAMICS OF THE QT INTERVAL IN MYOCARDIAL-INFARCTION
Authors: SINGH JP MUSIALEK P SLEIGHT P DAVEY P MARINHO M HART G
Citation: Jp. Singh et al., EFFECT OF ATENOLOL OR METOPROLOL ON WAKING HOUR DYNAMICS OF THE QT INTERVAL IN MYOCARDIAL-INFARCTION, The American journal of cardiology, 81(7), 1998, pp. 924
QT INTERVAL DYNAMICS AND HEART-RATE-VARIABILITY PRECEDING A CASE OF CARDIAC-ARREST
Authors: SINGH JP SLEIGHT P KARDOS A HART G
Citation: Jp. Singh et al., QT INTERVAL DYNAMICS AND HEART-RATE-VARIABILITY PRECEDING A CASE OF CARDIAC-ARREST, HEART, 77(4), 1997, pp. 375-377
EFFECTS OF CALCIUM-ANTAGONISTS ON THE RISKS OF CORONARY HEART-DISEASE, CANCER AND BLEEDING
Authors: ALDERMAN M ARAKAWA K BEILIN L CHALMERS J COHN J COLLINS R FENICHEL RR FROHLICH ED HAMET P HANSSON L HENNEKENS C KUSCHNIR E LIU LS MACMAHON S MANCIA G MARTIN I MENARD J SLEIGHT P WHITWORTH J YUSUF S ZANCHETTI A
Citation: M. Alderman et al., EFFECTS OF CALCIUM-ANTAGONISTS ON THE RISKS OF CORONARY HEART-DISEASE, CANCER AND BLEEDING, Journal of human hypertension, 11(6), 1997, pp. 331-342
LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS IS ASSOCIATED WITH ABNORMAL RATE ADAPTATION OF QT INTERVAL
Authors: SINGH JP JOHNSTON J SLEIGHT P BIRD R RYDER K HART G
Citation: Jp. Singh et al., LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS IS ASSOCIATED WITH ABNORMAL RATE ADAPTATION OF QT INTERVAL, Journal of the American College of Cardiology, 29(4), 1997, pp. 778-784
CLINICAL RELEVANCE OF ARTERIAL OXYGEN-SATURATION INSTABILITY TO DETECT BREATHING DISORDERS IN CHRONIC HEART-FAILURE
Authors: MORTARA A PINNA GD MAESTRI R PRPA A COBELLI F SLEIGHT P TAVAZZI L
Citation: A. Mortara et al., CLINICAL RELEVANCE OF ARTERIAL OXYGEN-SATURATION INSTABILITY TO DETECT BREATHING DISORDERS IN CHRONIC HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 7523-7523
LACK OF PERIPHERAL MODULATION OF CARDIOVASCULAR CENTRAL OSCILLATORY AUTONOMIC ACTIVITY DURING APNEA IN HUMANS
Authors: PASSINO C SLEIGHT P VALLE F SPADACINI G LEUZZI S BERNARDI L
Citation: C. Passino et al., LACK OF PERIPHERAL MODULATION OF CARDIOVASCULAR CENTRAL OSCILLATORY AUTONOMIC ACTIVITY DURING APNEA IN HUMANS, American journal of physiology. Heart and circulatory physiology, 41(1), 1997, pp. 123-129
EFFECTS OF CALCIUM-ANTAGONISTS ON THE RISKS OF CORONARY HEART-DISEASE, CANCER AND BLEEDING
Authors: ALDERMAN M ARAKAWA K BEILIN L CHALMERS J COHN J COLLINS R FENICHEL RR FROHLICH ED HAMET P HANSSON L HENNEKENS C KUSCHNIR E LIU LS MACMAHON S MANCIA G MARTIN I MENARD J SLEIGHT P WHITWORTH J YUSUF S ZANCHETTI A
Citation: M. Alderman et al., EFFECTS OF CALCIUM-ANTAGONISTS ON THE RISKS OF CORONARY HEART-DISEASE, CANCER AND BLEEDING, Journal of hypertension, 15(2), 1997, pp. 105-115
SELECTION OF REPERFUSION THERAPY FOR INDIVIDUAL PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION
Authors: VANDERWERF F VAHANIAN A GULBA DC MULLER J ARNOLD AER BAR F VERMEER F VERHEUGT FWA BOERSMA H VANES GA DECKERS JW LENDERINK T SIMOONS ML STEYERBERG E VANDERZWAAN C DEBOER MJ ZIJLSTRA F WILCOX RD SLEIGHT P SELKER HP CALIFF RM GRANGER C LEE KL OHMAN ME WEAVER DW LOVE T WHITE H CALIFF R COLLINS R
Citation: F. Vanderwerf et al., SELECTION OF REPERFUSION THERAPY FOR INDIVIDUAL PATIENTS WITH EVOLVING MYOCARDIAL-INFARCTION, European heart journal, 18(9), 1997, pp. 1371-1381
A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY
Authors: GRIP L FRISON L WALLENTIN L DELLBORG M GRANDE P HALINEN M HELD P MYHRE E RYDEN L SWAHN E SWEDBERG K THYGESEN K SLEIGHT P WILHELMSEN L NASLUND U GUNDERSEN T FISCHERHANSEN J LEHTO S BARRET M NILSSON JE TEGERNILSSON AC THORSEN M ANDERSEN F LUNDSTROM M HILDEBRAND A DEFLONOLSSON C FORSBY M ISBERG P LARSSON C NORGAARD B RASMUSSEN S VIDEBAEK J KLARLUND K LANDORPH A NIELSEN T AGNER E HOJGAARD MV HELQVIST S RASMUSSEN SL EGSTRUP K MYGIND L HANSEN JF SAJADIEH A GILL S HAGHFELT T MARKENVARD J THOMASSEN A JENSEN N PETERSEN J JENSEN G FISCHER T SIPILA R KIILAVUORI K HAMALAINEN L NURMINEN J MELIN J KOSKELA E HURME H VAUHONEN I HONKANEN T UTRIANEN S HAMALAINEN T LILJA M UKKOLVA O KIVELA H SODERSTROM S POHJOLASINTONEN S HUSSI E LARSEN A FALANG JE SCHARTUMHANSEN H PAULSEN A OMLAND T HOLM T EDVARDSEN T THYBO NK HAEREM J KAPELRUD H WAAGE K ROSSEBO B HAFSOY K HAMMARSTROM E ASTROM L HALL E WETTERVIK C FORSBERG SA TYGESEN H FREDRIKSSON B EKDAHL S KIHLSTROM K MAGNUSSON JO STJERNA A MARU F NILSSON H AKRAWI S SAETRE H AHLMARK G AHLBERG G LINDE B HAGSTROM L GUSTAFSSON G GUSTAVSSON PE LARSSON AC ANDERSEN K RUTER G KIERKEGAARD A HARDHAMMAR P KARLSSON JE SVENSSON O LANDGREN F HOLMBERG B RYDEN S WEINER L DANIELEWICZ M MALMROS B NICOL P JANZON M OHLIN H HANSEN O TINGBERG E NYMAN I FJELSTAD B AHLSTROM P HEDBACK B PERK J SVENNBERG L ELLSTROM J BOMAN K REMMETS J KRISTENSSON BE LINDER R HULTING J HOIJER J MOLLER BH LYCKSELL M WAHLIN M SANDSTEDT L REDFORS A BORRETZEN J OSTBERG G JOHANSSON B MORNER S LINDAHL B OLDGREN J JONSSON J NEMECZE K THORSEN S JOHANSSON PA SINNERSTAD B LARSSON LE BAND S MARSELL R
Citation: L. Grip et al., A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY, European heart journal, 18(9), 1997, pp. 1416-1425
FACTORS ASSOCIATED WITH IN-HOSPITAL DEATH FROM MYOCARDIAL-INFARCTION
Authors: VOLMINK J SLEIGHT P
Citation: J. Volmink et P. Sleight, FACTORS ASSOCIATED WITH IN-HOSPITAL DEATH FROM MYOCARDIAL-INFARCTION, European heart journal, 18(7), 1997, pp. 1046-1047
CLINICAL PERSPECTIVE ON RISK STRATIFICATION
Authors: SLEIGHT P
Citation: P. Sleight, CLINICAL PERSPECTIVE ON RISK STRATIFICATION, PACE, 20(10), 1997, pp. 2516-2519
LOWERING OF BLOOD-PRESSURE AND ARTERY STIFFNESS - REPLY
Authors: SLEIGHT P
Citation: P. Sleight, LOWERING OF BLOOD-PRESSURE AND ARTERY STIFFNESS - REPLY, Lancet, 349(9056), 1997, pp. 955-956
LOWERING OF BLOOD-PRESSURE AND ARTERY STIFFNESS
Authors: SLEIGHT P
Citation: P. Sleight, LOWERING OF BLOOD-PRESSURE AND ARTERY STIFFNESS, Lancet, 349(9048), 1997, pp. 362-362
DRUG-THERAPY - ASPIRIN, HEPARIN, AND FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION
Authors: COLLINS R PETO R BAIGENT C SLEIGHT P
Citation: R. Collins et al., DRUG-THERAPY - ASPIRIN, HEPARIN, AND FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION, The New England journal of medicine, 336(12), 1997, pp. 847-860
ABNORMAL AWAKE RESPIRATORY PATTERNS ARE COMMON IN CHRONIC HEART-FAILURE AND MAY PREVENT EVALUATION OF AUTONOMIC TONE BY MEASURES OF HEART-RATE-VARIABILITY (VOL 96, PG 246, 1997)
Authors: MORTARA A SLEIGHT P PINNA GD MAESTRI R PRPA A LAROVERE MT COBELLI F TAVAZZI L
Citation: A. Mortara et al., ABNORMAL AWAKE RESPIRATORY PATTERNS ARE COMMON IN CHRONIC HEART-FAILURE AND MAY PREVENT EVALUATION OF AUTONOMIC TONE BY MEASURES OF HEART-RATE-VARIABILITY (VOL 96, PG 246, 1997), Circulation, 96(11), 1997, pp. 4118-4118
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>